OCA
THC icon

OpenArc Corporate Advisory’s Tenet Healthcare THC Stock Holding History

OpenArc Corporate Advisory’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$428K Buy
+2,287
New +$420K 0.01% 531

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

OpenArc Corporate Advisory's THC Position: Q2 2026 in Review

OpenArc Corporate Advisory opened a new position in Tenet Healthcare (THC) in Q2 2026: 2,287 shares worth $428K. The stake represents 0.01% of the portfolio and ranks #531 among its holdings.

673 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • OpenArc Corporate Advisory held 2,287 shares of Tenet Healthcare worth $428K as of Q2 2026.
  • Tenet Healthcare was a new OpenArc Corporate Advisory position in Q2 2026.
  • Tenet Healthcare made up 0.01% of OpenArc Corporate Advisory's portfolio in Q2 2026, its #531 holding.
  • 673 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on OpenArc Corporate Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.